Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 7Uterine Neoplasms 1HER2/Neu Negative 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Paclitaxel 13pembrolizumab 8Carboplatin 7Cisplatin 5Docetaxel 4Brachytherapy 4Pemetrexed 3Gemcitabine 3Doxorubicin 3Biopsy 3osimertinib 2olaparib 2niraparib 2durvalumab 2adavosertib 2Trastuzumab 2Topotecan 2Taxes 2Standard of Care 2Sentinel Lymph Node Biopsy 2Saline Solution 2Radiotherapy 2Radiation 2Oxaliplatin 2Nivolumab 2Music Therapy 2Magnetic Resonance Spectroscopy 2Leucovorin 2Letrozole 2Immunoglobulin G 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uterine Neoplasms × 16-fluoroestradiol × Clear all
NCT05916196 2025-05-08

[18F]FES PET/.CT in Uterine Cancer

Abramson Cancer Center at Penn Medicine

Phase 2 Recruiting
30 enrolled
Gynecologic

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡